Reported 18 days ago
Kenvue's third-quarter sales were slightly below Wall Street expectations, primarily due to decreased sales in its skincare segment, including brands like Neutrogena. The company now predicts annual sales growth to be at the lower end of its forecast range of 1% to 3%. Despite struggling in skin health and beauty, Kenvue's self-care products have seen growth. However, the skincare segment's sales dropped 4.2%, culminating in a total revenue of $3.90 billion, which also fell short of estimates. Kenvue aims to enhance revenue through increased marketing efforts.
Source: YAHOO